Vanda Pharmaceuticals | DÍVIDA





DÍVIDA Alterar Data
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 48.76M 47.62M 2025-06
Akebia Therapeutics USD 46.51M 7.82M 2025-03
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Esperion Therapeutics USD 262.92M 1.76M 2024-09
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 564.56M 464K 2025-09
J&J USD 45.8B 4.97B 2025-09
Lexicon Pharmaceuticals USD 99.26M 493K 2023-09
Ligand Pharmaceuticals USD 5.74M 5.72M 2025-06
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 741M 4M 2025-06
Novartis USD 32.02B 615M 2025-09
Pfizer USD 60.85B 78M 2025-09
PTC Therapeutics USD 286.32M 306K 2025-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 21.76B 530M 2025-09
Takeda JPY 4.85T 208B 2025-12
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Veracyte USD 50.65M 145K 2025-06


Vanda Pharmaceuticals DÍVIDA - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.